Business Nurix reports 83% response rate for bexobrutideg in CLL patients Published 18 hours ago on 6 December 2025 By NewsAdmin Nurix reports 83% response rate for bexobrutideg in CLL patients Source link Related Topics: Up Next Musk, Trump admin shred $140M fine lodged by EU against X social media platform Don't Miss Dubai joins Global Resilient Cities Network Continue Reading Advertisement You may like Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.